Literature DB >> 21435188

Factors associated with serum brain natriuretic peptide levels after the Fontan procedure.

Andrew M Atz1, Victor Zak, Roger E Breitbart, Steven D Colan, Sara K Pasquali, Daphne T Hsu, Minmin Lu, Lynn Mahony, Stephen M Paridon, Michael D Puchalski, Tal Geva, Brian W McCrindle.   

Abstract

OBJECTIVE: Although a useful marker of heart failure in adults, the utility of brain natriuretic peptide concentration (BNP) for children after the Fontan procedure is not well studied.
DESIGN: BNP was measured in 510 patients who were 6-18 years old in the Pediatric Heart Network Fontan cross-sectional study at a median of 8.2 years after Fontan. Patients underwent echocardiography, exercise testing, magnetic resonance imaging (MRI) and functional health status questionnaires. Associations of BNP with baseline patient characteristics, medical history and cross-sectional assessment were examined with multivariable linear regression analyses.
RESULTS: The distribution of BNP was highly skewed, median 13.0 pg/mL (interquartile range: 7.1, 25.9), and was normalized with logarithmic transformation (logBNP). Among medical history variables, logBNP was greater in females (P= .02) and older patients (P < .001). Presence of pre-Fontan systolic ventricular dysfunction, greater number of post-Fontan complications, and thrombosis after Fontan were independently associated with higher logBNP (R(2) = 0.16). Age-adjusted logBNP was significantly related to Fontan connection type (lower with extracardiac conduits, higher with atriopulmonary connection; P < .001). Lower physical functioning health status (R(2) = 0.05), lower chronotropic index during exercise (R(2) = 0.17), indices of diastolic dysfunction measured by echocardiography (R(2) = 0.15), and higher total ventricular mass on MRI (R(2) = 0.33) were related to higher logBNP.
CONCLUSIONS: Despite a markedly abnormal circulation, BNP was variable but within a normal range in the majority of Fontan patients in this large outpatient cohort. Higher BNP was associated with several markers of suboptimal outcome, although associations were weak. The routine use of BNP as an outpatient surveillance tool in asymptomatic Fontan patients is not warranted.
© 2011 Copyright the Authors. Congenital Heart Disease © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435188      PMCID: PMC3134550          DOI: 10.1111/j.1747-0803.2011.00496.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  22 in total

1.  Measuring health-related quality of life in pediatric oncology patients: a brief commentary on the state of the art of measurement and application (discussion).

Authors:  J M Landgraf
Journal:  Int J Cancer Suppl       Date:  1999

2.  Increased levels of brain and atrial natriuretic peptides after the first palliative operation, but not after a bidirectional glenn anastomosis, in children with functionally univentricular hearts.

Authors:  Håkan Wåhlander; Andreas Westerlind; Göran Lindstedt; Per-Arne Lundberg; Daniel Holmgren
Journal:  Cardiol Young       Date:  2003-06       Impact factor: 1.093

3.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors:  Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

4.  Normal values of B type natriuretic peptide in infants, children, and adolescents.

Authors:  A Koch; H Singer
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

5.  Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study.

Authors:  Alan S Maisel; Paul Clopton; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Gabriel Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Vikas Bhalla; Howard C Herrmann; Marie Claude Aumont; Peter A McCullough
Journal:  Am Heart J       Date:  2004-06       Impact factor: 4.749

6.  B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection.

Authors:  Andreas M E Koch; Stefan Zink; Helmut Singer; Sven Dittrich
Journal:  Eur J Heart Fail       Date:  2008-01       Impact factor: 15.534

7.  Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study.

Authors:  Page A W Anderson; Lynn A Sleeper; Lynn Mahony; Steven D Colan; Andrew M Atz; Roger E Breitbart; Welton M Gersony; Dianne Gallagher; Tal Geva; Renee Margossian; Brian W McCrindle; Stephen Paridon; Marcy Schwartz; Mario Stylianou; Richard V Williams; Bernard J Clark
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

8.  Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Venkatakrishna N Tholakanahalli; Andrey G Zenovich; Susan A Casey; Daniel Duprez; Dorothee M Aeppli; Jay N Cohn
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

9.  Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone.

Authors:  Amy K Saenger; Daniel A Dalenberg; Sandra C Bryant; Stefan K Grebe; Allan S Jaffe
Journal:  Clin Chem       Date:  2009-08-13       Impact factor: 8.327

10.  Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study.

Authors:  Yuk M Law; Andrew W Hoyer; Mark D Reller; Michael Silberbach
Journal:  J Am Coll Cardiol       Date:  2009-10-06       Impact factor: 24.094

View more
  14 in total

1.  Alkaline Phosphatase: A Biomarker of Cardiac Function in Pediatric Patients.

Authors:  Elizabeth S Makil; Xinyu Tang; Elizabeth A Frazier; R Thomas Collins
Journal:  Pediatr Cardiol       Date:  2017-02-09       Impact factor: 1.655

2.  Increase in N-terminus-pro-B-type natriuretic peptide during exercise of patients with univentricular heart after a total cavopulmonary connection.

Authors:  Alfred Hager; Florian Christov; John Hess
Journal:  Pediatr Cardiol       Date:  2012-02-29       Impact factor: 1.655

3.  Heart failure in adult congenital heart disease.

Authors:  Ada Stefanescu; Doreen DeFaria Yeh; David M Dudzinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

4.  Cardiac performance and quality of life in patients who have undergone the Fontan procedure with and without prior superior cavopulmonary connection.

Authors:  Andrew M Atz; Thomas G Travison; Brian W McCrindle; Lynn Mahony; Andrew C Glatz; Aditya K Kaza; Roger E Breitbart; Steven D Colan; Jonathan R Kaltman; Renee Margossian; Sara K Pasquali; Yanli Wang; Welton M Gersony
Journal:  Cardiol Young       Date:  2012-07-24       Impact factor: 1.093

5.  Preoperative B-type natriuretic peptide levels are associated with outcome after total cavopulmonary connection (Fontan).

Authors:  Monique Radman; Roberta L Keller; Peter Oishi; Sanjeev A Datar; Kari Wellnitz; Anthony Azakie; Frank Hanley; Danton Char; Jong-Hau Hsu; Rambod Amrinovin; Ian Adatia; Jeffrey R Fineman
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-27       Impact factor: 5.209

6.  Assessment of Quality of Life in Young Patients with Single Ventricle after the Fontan Operation.

Authors:  Karen Uzark; Victor Zak; Peter Shrader; Brian W McCrindle; Elizabeth Radojewski; James W Varni; Kaitlyn Daniels; Jill Handisides; Kevin D Hill; Linda M Lambert; Renee Margossian; Victoria L Pemberton; Wyman W Lai; Andrew M Atz
Journal:  J Pediatr       Date:  2015-12-10       Impact factor: 4.406

7.  Usefulness of insulin like growth factor 1 as a marker of heart failure in children and young adults after the Fontan palliation procedure.

Authors:  Catherine M Avitabile; Mary B Leonard; Jill L Brodsky; Kevin K Whitehead; Chitra Ravishankar; Meryl S Cohen; J William Gaynor; Jack Rychik; David J Goldberg
Journal:  Am J Cardiol       Date:  2015-01-06       Impact factor: 2.778

8.  Factors associated with serum B-type natriuretic peptide in infants with single ventricles.

Authors:  Ryan J Butts; Victor Zak; Daphne Hsu; James Cnota; Steven D Colan; David Hehir; Paul Kantor; Jami C Levine; Renee Margossian; Marc Richmond; Anita Szwast; Derek Williams; Richard Williams; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2014-02-13       Impact factor: 1.655

Review 9.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

10.  Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure.

Authors:  Andrew M Atz; Victor Zak; Lynn Mahony; Karen Uzark; Nicholas D'agincourt; David J Goldberg; Richard V Williams; Roger E Breitbart; Steven D Colan; Kristin M Burns; Renee Margossian; Heather T Henderson; Rosalind Korsin; Bradley S Marino; Kaitlyn Daniels; Brian W McCrindle
Journal:  J Am Coll Cardiol       Date:  2017-06-06       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.